| Product Code: ETC4710376 | Publication Date: Nov 2023 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
Israel`s erythromycin import shipments in 2024 saw a diverse range of top exporting countries, including Belgium, Switzerland, Canada, Germany, and the Netherlands. Despite this variety, the market remained relatively unconcentrated with a low Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) from 2020 to 2024 was steady at 0.79%, but there was a notable decline in growth from 2023 to 2024 at -22.67%. This fluctuation suggests potential shifts in market dynamics that importers and stakeholders should monitor closely for strategic decision-making.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Erythromycin Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Erythromycin Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Erythromycin Market - Industry Life Cycle |
3.4 Israel Erythromycin Market - Porter's Five Forces |
3.5 Israel Erythromycin Market Revenues & Volume Share, By Formulation, 2021 & 2031F |
3.6 Israel Erythromycin Market Revenues & Volume Share, By Therapeutic Indications, 2021 & 2031F |
3.7 Israel Erythromycin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Erythromycin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in Israel |
4.2.2 Growing awareness about the effectiveness of erythromycin in treating various infections |
4.2.3 Rising demand for antibiotics due to a growing population and changing lifestyles |
4.3 Market Restraints |
4.3.1 Stringent regulations and approvals required for the sale of antibiotics |
4.3.2 Increasing concerns about antibiotic resistance leading to limited usage of erythromycin |
5 Israel Erythromycin Market Trends |
6 Israel Erythromycin Market Segmentations |
6.1 Israel Erythromycin Market, By Formulation |
6.1.1 Overview and Analysis |
6.1.2 Israel Erythromycin Market Revenues & Volume, By Gel, 2021-2031F |
6.1.3 Israel Erythromycin Market Revenues & Volume, By Tablet, 2021-2031F |
6.1.4 Israel Erythromycin Market Revenues & Volume, By Topical Solution, 2021-2031F |
6.1.5 Israel Erythromycin Market Revenues & Volume, By Ointment, 2021-2031F |
6.1.6 Israel Erythromycin Market Revenues & Volume, By Others, 2021-2031F |
6.2 Israel Erythromycin Market, By Therapeutic Indications |
6.2.1 Overview and Analysis |
6.2.2 Israel Erythromycin Market Revenues & Volume, By Respiratory Tract Infections, 2021-2031F |
6.2.3 Israel Erythromycin Market Revenues & Volume, By Eye Infections, 2021-2031F |
6.2.4 Israel Erythromycin Market Revenues & Volume, By Ear Infections, 2021-2031F |
6.2.5 Israel Erythromycin Market Revenues & Volume, By Skin and Soft Tissue Infections, 2021-2031F |
6.2.6 Israel Erythromycin Market Revenues & Volume, By Gastro-intestinal Infections, 2021-2031F |
6.2.7 Israel Erythromycin Market Revenues & Volume, By Others, 2021-2031F |
6.3 Israel Erythromycin Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Erythromycin Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 Israel Erythromycin Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.4 Israel Erythromycin Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 Israel Erythromycin Market Import-Export Trade Statistics |
7.1 Israel Erythromycin Market Export to Major Countries |
7.2 Israel Erythromycin Market Imports from Major Countries |
8 Israel Erythromycin Market Key Performance Indicators |
8.1 Rate of prescriptions for erythromycin by healthcare providers |
8.2 Number of clinical trials and research studies on erythromycin in Israel |
8.3 Patient adherence and compliance to erythromycin treatment plans |
9 Israel Erythromycin Market - Opportunity Assessment |
9.1 Israel Erythromycin Market Opportunity Assessment, By Formulation, 2021 & 2031F |
9.2 Israel Erythromycin Market Opportunity Assessment, By Therapeutic Indications, 2021 & 2031F |
9.3 Israel Erythromycin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Erythromycin Market - Competitive Landscape |
10.1 Israel Erythromycin Market Revenue Share, By Companies, 2024 |
10.2 Israel Erythromycin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here